Cecilia Jay

ORCID: 0000-0003-2387-9225
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • COVID-19 epidemiological studies
  • Influenza Virus Research Studies
  • Viral gastroenteritis research and epidemiology
  • SARS-CoV-2 detection and testing
  • vaccines and immunoinformatics approaches
  • Immunotherapy and Immune Responses
  • Long-Term Effects of COVID-19
  • Acute Ischemic Stroke Management
  • Radiation Dose and Imaging
  • COVID-19 Impact on Reproduction
  • MRI in cancer diagnosis

Medawar Building for Pathogen Research
2021-2024

University of Oxford
2021-2024

The extent to which immune responses natural infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and immunization vaccines protect against variants of concern (VOC) is increasing importance. Accordingly, here we analyse antibodies T cells a recently vaccinated, UK cohort, alongside those recovering from in early 2020. We show that neutralization the VOC compared reference isolate original circulating lineage, B, reduced: more profoundly B.1.351 than for B.1.1.7, or...

10.1038/s41467-021-25167-5 article EN cc-by Nature Communications 2021-08-17
Adriana Tomić Donal Skelly Ane Ogbe Daniel O’Connor Matthew Pace and 95 more Emily Adland Frances Alexander Mohammad Ali Kirk Allott M. Azim Ansari Sandra Belij‐Rammerstorfer Sagida Bibi Luke Blackwell Anthony Brown Helen Brown Breeze E. Cavell Elizabeth Clutterbuck Thushan I. de Silva David W. Eyre Sheila Lumley Amy Flaxman James T. Grist Carl-Philipp Hackstein Rachel Halkerston Adam Harding Jennifer Hill Tim James Cecilia Jay Síle A. Johnson Barbara Kronsteiner Yolanda Lie Aline Linder Stephanie Longet Spyridoula Marinou Philippa C. Matthews Jack Mellors Christos J. Petropoulos Patpong Rongkard Cynthia Sedik Laura Silva-Reyes Holly Smith Lisa Stockdale Stephen Taylor Stephen J. Thomas Timothy Tipoe Lance Turtle Vinícius Vieira Terri Wrin Lizzie Stafford Hibatullah Abuelgasim Ahmed Alhussni Carolina V. Arancibia-Cárcamo Martyna Borak Joseph Cutteridge Alexandra Deeks Lucy Denly Stavros Dimitriadis Shayan Fassih Thomas Foord Thomas Fordwoh Jennifer Holmes Bryn Horsington Sven Kerneis David Kim Katy Lillie Jordan Morrow Denise O’Donnell Thomas Ritter Beatrice Simmons A Taylor Sarah Thomas Yolanda Warren Adam Watson Esme Weeks Robert Wilson Rebecca Young C.J. Duncan Shona C. Moore Rebecca P. Payne Alex Richter Sarah Rowland–Jones Alexander J. Mentzer Mark Philip Cassar Tao Dong Anastasia Fries Javier Gilbert‐Jaramillo Ling‐Pei Ho Julian C. Knight Stefan Neubauer Yanchun Peng Nayia Petousi Betty Raman Nick P. Talbot Andrew J. Pollard Teresa Lambe Chris Conlon Katie Jeffery Simon Travis Philip Goulder John Frater

Abstract The trajectories of acquired immunity to severe acute respiratory syndrome coronavirus 2 infection are not fully understood. We present a detailed longitudinal cohort study UK healthcare workers prior vaccination, presenting April-June 2020 with asymptomatic or symptomatic infection. Here we show highly variable range responses, some which (T cell interferon-gamma ELISpot, N-specific antibody) wane over time, while others (spike-specific antibody, B memory ELISpot) stable. use...

10.1038/s41467-022-28898-1 article EN cc-by Nature Communications 2022-03-10

Introduction The key to understanding the COVID-19 correlates of protection is assessing vaccine-induced immunity in different demographic groups. Young people are at a lower risk mortality, females than males, and often generate stronger immune responses vaccination. Methods We studied two doses BNT162b2 Pfizer vaccine an adolescent cohort (n = 34, ages 12–16), age group previously shown elicit significantly greater same young adults. Adolescents were with aim comparing their response that...

10.3389/fimmu.2023.1248630 article EN cc-by Frontiers in Immunology 2023-10-06

Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is normally controlled by effective host immunity including innate, humoral and cellular responses. However, the trajectories correlates of acquired immunity, capacity memory responses months after to neutralise variants concern - which has important public health implications not fully understood. To address this, we studied a cohort 78 UK healthcare workers who presented in April June 2020 with symptomatic...

10.21203/rs.3.rs-612205/v1 preprint EN cc-by Research Square (Research Square) 2021-06-15

Tools to detect SARS-CoV-2 variants of concern and track the ongoing evolution virus are necessary support public health efforts design evaluation novel COVID-19 therapeutics vaccines. Although next-generation sequencing (NGS) has been adopted as gold standard method for discriminating lineages, alternative methods may be required when processing samples with low viral loads or RNA quality. To this aim, an allele-specific probe PCR (ASP-PCR) targeting lineage-specific single nucleotide...

10.1128/jcm.02283-21 article EN Journal of Clinical Microbiology 2022-03-25

mRNA vaccine technologies introduced following the SARS-CoV-2 pandemic have highlighted need to better understand interaction of adjuvants and early innate immune response. Type I interferon (IFN-I) is an integral part this response that primes several components adaptive Women are widely reported respond than men tri- quadrivalent influenza vaccines. Plasmacytoid dendritic cells (pDCs) primary cell type responsible for IFN-I production, female pDCs produce more male since upstream pattern...

10.3389/fimmu.2024.1329805 article EN cc-by Frontiers in Immunology 2024-02-28

Introduction Family studies of antiviral immunity provide an opportunity to assess virus-specific in infected and highly exposed individuals, as well examine the dynamics viral infection within families. Transmission SARS-CoV-2 between family members represented a major route for spread during early stages pandemic, due nature transmission through close contacts. Methods Here, humoral cellular is explored 264 infected, or unexposed individuals from 81 families United Kingdom sampled winter...

10.3389/fimmu.2023.1248658 article EN cc-by Frontiers in Immunology 2023-08-29

Abstract Key to understanding COVID-19 correlates of protection is assessing vaccine-induced immunity in different demographic groups. Sex- and age-specific immune differences have a wide impact on outcomes from infections immunisations. Typically, adult females make stronger responses better disease but suffer more adverse events following vaccination are prone autoimmune disease. To understand the mechanisms underlying these vaccine responses, we studied two doses BNT162b2 Pfizer an...

10.1101/2023.07.24.23293091 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2023-07-27

Background: There is no guideline for imaging post endovascular therapy (EVT). MRI considered superior to noncontrast CT assessment of final infarct volume and distinguish contrast from hemorrhage. We sought align the EVT practices with those after intravenous thrombolysis Methods: reviewed EMR records all patients Jan 1, 2019 Dec 31, 2021. assessed quantity within 24h EVT, MRIs performed, indications listed. then undertook an educational program targeting stakeholders. The objective was...

10.1017/cjn.2024.102 article EN Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 2024-05-24

Abstract mRNA vaccine technologies introduced following the SARS-CoV-2 pandemic have highlighted need to better understand interaction of adjuvants and early innate immune response. Interferon type I (IFN-I) is an integral part this response can prime several components adaptive Females are widely reported respond than males seasonal tri- quad-valent influenza vaccines. Plasmacytoid dendritic cells (pDCs) primary cell responsible for IFN-I production female pDCs produce more male since...

10.1101/2023.08.01.551423 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2023-08-02

Abstract Introduction Tools to detect SARS-Coronavirus-2 variants of concern and track the ongoing evolution virus are necessary support public health efforts design evaluation novel COVID-19 therapeutics vaccines. Although next-generation sequencing (NGS) has been adopted as gold standard method for discriminating SARS-CoV-2 lineages, alternative methods may be required when processing samples with low viral loads or RNA quality. Methods An allele-specific probe polymerase chain reaction...

10.1101/2021.11.01.21265384 preprint EN cc-by-nc medRxiv (Cold Spring Harbor Laboratory) 2021-11-02
Coming Soon ...